UNIVASC (nda020312)- (7.5MG,15MG)

Generic Name	MOEXIPRIL HYDROCHLORIDE	Innovator	UCB INC
Dosage	7.5MG,15MG
ParaIV Filing	Yes	505(b)2 Filing	No
Last Patent Expiry	2007-Feb-24	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	Univasc® is indicated for treatment of patients with hypertension.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
4	0	2

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
7.5MG	**	**	-	2	-
15MG	**	**	-	-	2

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	2

Manufacturing Details of UNIVASC